| |
| |
|
| Insider
Information: |
Ali Asif |
| Relationship: |
Chief Financial Officer |
| City: |
Newark |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
37,163 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,089,619 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
37,163 |
|
|
| Total
Value |
$1,089,619 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Protagonist Therapeutics, Inc |
PTGX |
Chief Financial Officer |
2024-04-18 |
37,163 |
2022-04-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PTGX |
Protagonist Therapeutics,... |
Chief Financial Officer |
• – – |
2024-04-18 |
4 |
S |
$25.11 |
$30,986 |
D/D |
(1,234) |
37,163 |
0 |
% |
|
| PTGX |
Protagonist Therapeutics,... |
Chief Financial Officer |
• – – |
2024-03-01 |
4 |
S |
$32.22 |
$459,318 |
D/D |
(14,248) |
38,397 |
0 |
% |
|
| PTGX |
Protagonist Therapeutics,... |
Chief Financial Officer |
• – – |
2024-03-01 |
4 |
OE |
$12.17 |
$146,040 |
D/D |
12,000 |
52,645 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
Chief Financial Officer |
• – – |
2024-02-29 |
4 |
S |
$30.61 |
$305,048 |
D/D |
(9,939) |
40,645 |
0 |
% |
|
| PTGX |
Protagonist Therapeutics,... |
Chief Financial Officer |
• – – |
2024-01-16 |
4 |
D |
$24.63 |
$35,763 |
D/D |
(1,452) |
50,584 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
Chief Financial Officer |
• – – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
21,000 |
52,036 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
Chief Financial Officer |
• – – |
2023-05-31 |
4 |
D |
$26.07 |
$108,191 |
D/D |
(4,150) |
31,036 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
Chief Financial Officer |
• – – |
2023-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
35,186 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
Chief Financial Officer |
• – – |
2023-04-18 |
4 |
D |
$23.21 |
$27,597 |
D/D |
(1,189) |
23,186 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
Chief Financial Officer |
• – – |
2023-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
10,625 |
24,375 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
Chief Financial Officer |
• – – |
2022-04-18 |
4 |
A |
$0.00 |
$0 |
D/D |
13,750 |
13,750 |
0 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
